Surekha Surendranathan

Statistics

Publications

Citations

351

H-Index

Active since

2020

Affiliations

University of Tennessee Health Science Center(Current)

Oak Ridge National Laboratory

Argonne National Laboratory

University of Chicago

Los Alamos National Laboratory

Surekha Surendranathan is an author at University of Tennessee Health Science Center specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2020–2023

Publications

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease

Daniel W. Kneller, Hui Li, G.N. Phillips et al. · Nature Communications · 2022 · 124 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

Brian Sanders, Suman Pokhrel, Audrey Labbé et al. · Nature Communications · 2023 · 93 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Virtual and <i>In Vitro</i> Antiviral Screening Revive Therapeutic Drugs for COVID-19

Giovanni Bocci, Steven B. Bradfute, Chunyan Ye et al. · ACS Pharmacology & Translational Science · 2020 · 60 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and <i>In Vitro</i> Study

Souvik Banerjee, Souvik Banerjee, Shalini Yadav et al. · Journal of Chemical Information and Modeling · 2021 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2

Rajendra P. Joshi, Katherine Schultz, Jesse Wilson et al. · Journal of Chemical Information and Modeling · 2023 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 6